We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zosano Pharma Presents Positive Phase 2 Results of Its Needle-Free Osteoporosis Therapy

News   Apr 06, 2009

 
Zosano Pharma Presents Positive Phase 2 Results of Its Needle-Free Osteoporosis Therapy
 
 
 

RELATED ARTICLES

Discontinuing Oral Immunotherapy for Peanut Allergy Reduces Its Protective Effects

News

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

READ MORE

Some Cancer Drugs Don’t Work by Hitting Their Targets

News

Some cancer drug candidates in clinical trials kill cancerous cells through off-target effects instead of by interacting with their intended molecular targets, according to new study findings.

READ MORE

Hidden Differences May Help Cells Evade Drug Therapy

News

Seemingly identical cells can use different protein molecules to carry out the same function in an important cellular process. Scientists have named this variability “functional mosaicism”. It could have significant implications for the development of therapeutic treatments.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE